The NHS, wellbeing, fitness and medical breakthroughs.
The UK Health Security Agency has warned of health risks across London, the South East and parts of eastern and central England as temperatures climb, with older and unwell people most at risk.
A walkout that threatened to coincide with a heatwave and the World Cup was suspended hours before it began, after the BMA and government struck a revised pay and jobs offer now heading to a members' vote.
From 23 June, more people in England will qualify for tirzepatide on the NHS as the BMI threshold for primary-care prescribing drops, in the next phase of a carefully managed rollout.
An experimental cell therapy first developed for cancer has driven severe lupus into remission in early NHS trials, with researchers hopeful it could one day help treat other autoimmune conditions.
Early results from a UCL and UCLH study suggest a single dose of CAR T-cell therapy can switch off severe, treatment-resistant lupus, with five of six lower-dose patients reaching remission within months.
Health officials have announced a one-off MenB vaccination drive for Year 13 pupils and young people starting university this autumn, following a meningitis outbreak in Kent.
Year 13 pupils and new students will be offered a two-dose meningitis B vaccine from late July, in an emergency programme launched after the UK's largest and fastest-growing MenB outbreak.
An international study published in the journal Cell finds that mutations linked to blood cancers can drive harmful brain inflammation, hinting at new ways to screen for and treat Alzheimer's.
GPs in England will be able to prescribe the weight-loss drug Mounjaro to a wider group of patients from late June, as the NHS lowers the BMI threshold for the next phase of its rollout.
The UK Health Security Agency has warned that falling childhood vaccination rates are leaving communities exposed, after a rise in measles cases across several regions.
Around 400 women a year with platinum-resistant ovarian cancer will be offered Elahere, a targeted therapy shown to extend survival compared with standard chemotherapy.
A major international trial led by UK researchers found that a 50-gene tumour test can safely identify many women who gain no benefit from chemotherapy, with near-identical survival five years on.